News & Updates

A recent study has shown the inverse associations of plasma phospholipid proportions of linoleic acid (LA) and α-linolenic acid (ALA), biomarkers of vegetable oil intake, during childhood and adolescence with measures of obesity and cardiometabolic health in young adulthood. A potential sex difference has also been observed.

Adolescents with a short sleep duration whether with or without insomnia may be at an increased risk of elevated blood pressure (BP) than those with a normal sleep duration, according to a study presented at the EPI|Lifestyle Scientific Sessions 2025.

Lebrikizumab improves anxiety and depression symptoms, as shown by PROMIS* scores, in patients with moderate-to-severe atopic dermatitis (AD), according to the ADore trial presented at AAAAI/WAO 2025.

Eliminating certain foods such as egg and milk from children’s diet due to IgE-mediated allergy may hinder growth, but oral immunotherapy helps improve growth trajectories, especially when initiated at a younger age, according to two studies.

Twice-daily application of ruxolitinib cream appears effective and well tolerated in the treatment of mild-to-moderate atopic dermatitis (AD) regardless of age, based on a pooled analysis of three phase III trials presented at AAAAI/WAO 2025.

New drug applications approved by US FDA as of 16-28 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The introduction of pneumococcal conjugate vaccines (PCV) into Singapore's National Childhood Immunisation Schedule (NCIS) has reduced the incidence of invasive pneumococcal disease (IPD) in children by nearly a third, as reported in a study.